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Introduction {#sec1}
============

The clearance of invading microbes and the establishment of enduring protection from harmful pathogens depends on B cell differentiation into plasma cells (PCs) that secrete high-affinity antibodies. These cells are generated in microanatomical sites, known as germinal centers (GCs), which emerge in lymphoid organs primarily in response to vaccination or pathogen invasion ([@bib64]). In these sites, B cells that express antigen-specific B cell receptors (BCRs) undergo clonal diversification by somatic hypermutation (SHM) and affinity-based clonal selection ([@bib6], [@bib26]), and subsequently emerge as either memory or antibody-secreting cells ([@bib17]). Both entry into the GC and the selection of B cells bearing high-affinity BCR variants are regulated by T follicular helper (Tfh) cells, specialized CD4^+^ T cells that physically interact with B cells and distinguish high- versus low-affinity clones, based on their capacity to take up and present surface antigens ([@bib60], [@bib65], [@bib66]). Although this process was intensively studied in lymph nodes (LNs) and spleen in response to immunization, it is not clear whether Tfh cells play a similar role in chronic GC responses within intestinal lymphoid organs.

The composition of the gut microbiota is modulated by a relatively stable PC population that resides in the gut and secretes immunoglobulin A (IgA) antibodies that bind various specific bacterial epitopes and maintain the homeostatic balance between the host and commensal bacteria ([@bib28], [@bib33], [@bib43]). Class switching to the IgA isotype takes place within Peyer's patches (PPs) ([@bib18]), predominantly in an area known as the subepithelial dome (SED) ([@bib10], [@bib55]). As opposed to class switch recombination (CSR) of B cells to IgG1 within draining LNs and spleen in response to immunization or microbe invasion, switching to the IgA isotype in PPs can take place in the absence of T cell-derived signals ([@bib7], [@bib47], [@bib50]). It remains unknown whether other B cell functions in chronic GCs, such as clonal diversification and affinity-based selection, require T cell help.

The BCR plays a dual role during cognate antigen recognition; it propagates signal transduction and mediates the uptake of antigens for processing and presentation on surface major histocompatibility complex class II (MHC class II) molecules to Tfh cells ([@bib41], [@bib64]). Surface and secreted help signals from T cells to B cells are essential for GC formation and function in LNs and spleen ([@bib66]). Nonetheless, several studies that examined GCs in mucosal tissues provided evidence that challenges this model. RAG-deficient mice that were crossed to transgenic strains carrying a single and non-cognate T cell receptor (TCR) and BCR were able to form GC structures in PPs ([@bib4]). Furthermore, it was found that BCR-deficient B cells that express the Epstein-Barr virus (EBV) protein LMP2A were unable to form GCs in the spleen in response to immunization. Although antigen uptake and presentation cannot take place in the absence of a BCR, GC structures were detected in the gut-associated lymphoid tissues (GALTs) of LMP2A transgenic mice ([@bib15]). Moreover, it was demonstrated that in transgenic mice in which nearly all of the B cells are specific for a single antigen, GCs were formed in PPs, despite the fact that these B cells never encountered their cognate antigen ([@bib15], [@bib70]). In addition, highly mutated and expanded clones specific for lipopolysaccharides (LPS; an antigen that drives T cell-independent responses) were found in the human gut, suggesting that these cells originated from the GC response, although they were unable to present peptides to T cells ([@bib39]). Nevertheless, T cells play a critical role in these responses, since GC formation in PPs and mesenteric LNs (mLNs) does not take place in T cell- and CD40-deficient mice ([@bib7], [@bib15], [@bib43], [@bib47]). These observations indicate that the T cell help mechanisms in chronic GC reactions in PPs do not necessarily play an identical role to those in GC responses that emerge within LNs in response to immunization. Accordingly, it seems that a more complex B cell response takes place in the gut, which cannot be simply classified according to the traditional T cell-dependent versus independent dichotomy.

Tfh cells express high levels of the cytoplasmic signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), encoded by the *Sh2d1a* gene ([@bib19], [@bib49], [@bib59]). SAP functions as an inhibitor of negative signals by competing with SHP1 for the binding of the immunoreceptor tyrosine-based switch motifs (ITSM) domain in the cytoplasmic tail of Ly108, a member of the SLAM receptor family ([@bib16], [@bib37]). This adaptor is critical for Tfh cell functions, as T cells deficient in SAP are unable to promote GC formation as a result of defects in their development and in their ability to deliver proper T cell help signals to B cells ([@bib11], [@bib13], [@bib14], [@bib53], [@bib59]). Furthermore, it was shown that T cell functions and SAP expression are required for GC maintenance in the spleen and LNs ([@bib36], [@bib73]). Mucosal lymphoid organs such as PPs and mLNs perpetually collect bacteria-derived antigens, and therefore constitutively host GC reactions ([@bib54]). It remained to be determined whether SAP-mediated T cell help plays a role in these chronic GCs during homeostasis similar to that observed in inducible GC reactions in peripheral LNs.

In the present study, we examined the role of SAP in regulating chronic GC reactions that form in response to commensal bacteria- and dietary-derived antigens. We found that SAP is not required for the formation of GCs in PPs and for clonal diversification of B cells; however, SAP-mediated T cell help is essential for proper B cell selection within chronic GCs in PPs. We conclude that T cell help to B cells in PP GCs involves both SAP-dependent and SAP-independent functions.

Results {#sec2}
=======

SAP-Deficient Mice Host Small GCs within PPs {#sec2.1}
--------------------------------------------

SAP-mediated T cell help is essential for mounting a T cell-dependent immune response in draining LNs and spleen in response to immunization or microbe invasion, but it is not known whether this adaptor protein regulates chronic immune responses in the gut. To examine the role of SAP in GC formation in PPs, we imaged GCs of wild-type (WT), SAP knockout (SAP^KO^), and T cell-deficient mice (TCRα^KO^) by deep scanning of intact organs using two-photon laser scanning microscopy (TPLSM). In PPs, the enzyme activation-induced cytidine deaminase (AID) is expressed primarily by GC B cells and to a lesser extent by activated B cells located within the SED ([@bib10], [@bib55]). To clearly visualize GC structures in SAP- and TCRα-deficient mice, we crossed these strains to mice that express Cre recombinase under the AID promoter together with a conditional tdTomato reporter cassette (Aicda^Cre/+^ Rosa26^Stop-tdTomato/+^). In these mice, tdTomato is upregulated by cells that express AID or previously expressed AID ([@bib56]).

We examined GC formation in popliteal LNs of the AID reporter mice in response to subcutaneous immunization with 4-hydroxy-3-nitrophenyl acetyl (NP) conjugated to ovalbumin (NP-OVA) in alum. As expected, 7 days after immunization, GC structures were evident in the LNs of WT, but not in SAP- or TCRα-deficient mice ([Figure 1](#fig1){ref-type="fig"}A). Close analysis of the LNs from either SAP- or TCRα-deficient immunized mice revealed that tdTomato-expressing B cells were scattered throughout the LN cortex, demonstrating that T cell help is essential for GC formation but not for initial AID expression ([Figure 1](#fig1){ref-type="fig"}A). Similar analysis of PPs and mesenteric LNs derived from these WT mice, which host B cell responses to commensal bacteria- and food-derived antigens, revealed clear GC structures ([Figures 1](#fig1){ref-type="fig"}B--1E). However, in sharp contrast to the defect observed in the LNs of SAP-deficient mice, GCs were clearly observed in the PPs and mLNs of these mice. These GCs were T cell dependent, as no GC structures were detected in the PPs and mLNs of TCRα-deficient mice ([Figures 1](#fig1){ref-type="fig"}B--1E). The AID^Cre/+^ Rosa26^Stop-tdTomato/+^ strain is a fate reporter mouse that does not necessarily identify cells that currently express AID and engage in the GC reaction. To examine whether AID is specifically expressed in the GCs of SAP-deficient mice, we imaged PPs derived from an AID-GFP reporter strain ([@bib56]). To this end, these mice were crossed to SAP- or TCRα-deficient mice and their PPs were subjected to whole LN scan by TPLSM. This analysis revealed clusters of AID-expressing B cells in SAP-deficient mice that were smaller compared to those in AID-GFP WT control mice ([Figures 1](#fig1){ref-type="fig"}F and 1G). Miniscule GC-like structures were also detected in the TCRα-deficient AID-GFP mice, although these were significantly smaller than the ones observed in WT and SAP-deficient mice ([Figure 1](#fig1){ref-type="fig"}G). We conclude, therefore, that SAP is not essential for the generation of GC structures that contain AID-expressing B cells in PPs.Figure 1Small GC Structures Are Formed in PPs of SAP-Deficient Mice(A) TPLSM images of popliteal LNs derived from AID^Cre/+^ Rosa26^Stop-tdTomato/+^ WT, SAP^KO^, or TCRα^KO^ mice 7 days after intra-footpad NP-OVA immunization. One day before imaging, naive CFP B cells were transferred to the mice. Scale bar, 200 μm.(B and C) TPLSM images of mesenteric LNs (B) and PPs (C). Scale bar, 200 μm.(D) Number of GC structures per PP in WT, SAP^KO^, and TCRα^KO^ mice.(E) Quantification of GC area of TPLSM images of the mice as shown in (C).(F) TPLSM images of PPs derived from AID-GFP WT, SAP^KO^, or TCRα^KO^ mice. Scale bar, 200 μm.(G) Quantification of GC area from TPLSM images of the mice as shown in (F).Data are pooled from three independent experiments with two mice in each experiment. Each dot in (D) represents a single PP; each dot in (E) and (G) represents a single GC structure; line represents the mean. ^∗^p \< 0.05, ^∗∗∗^p \< 0.0001, one-way ANOVA with Bonferroni posttest. ns, not significant.

GC B Cells in SAP-Deficient Mice Express Typical Markers {#sec2.2}
--------------------------------------------------------

To further examine whether SAP-deficient mice host conventional GCs, we stained popliteal LN and PP cells with antibodies that detect typical GC markers (e.g., CD38^−^, FAS^+^). As expected, in WT mice, GCs were generated in response to immunization with NP-OVA in alum, whereas no GCs were detected in LNs derived from SAP- or TCRα-deficient mice ([Figures 2](#fig2){ref-type="fig"}A and 2B). In addition, no GC cells were detected in PPs derived from TCRα^KO^ mice; however, significant frequencies of GC cells were detected in the PPs of unimmunized SAP-deficient mice---3.4-fold lower than in WT ([Figures 2](#fig2){ref-type="fig"}A and 2C). In addition, GCs in the PPs of SAP-deficient mice showed normal distribution between the dark zone (DZ) and light zone (LZ) compartments ([Figure 2](#fig2){ref-type="fig"}D). Bcl6 is a key transcription factor that is essential for reprogramming activated B cells to differentiate into GC B cells ([@bib3]). B cells from WT and SAP-deficient mice expressed similar levels of mRNA transcripts and protein of Bcl6 ([Figures 2](#fig2){ref-type="fig"}E and 2F). These findings indicate that the GC structures observed in the PPs of SAP-deficient mice are bona fide GCs.Figure 2GC B Cells in PPs of SAP-Deficient Mice Express Typical Markers(A) Representative flow cytometry plots showing GC B cells (CD38^−^ FAS^+^) in popliteal LNs (top panel) 7 days after intra-footpad NP-OVA immunization and in PPs of WT, SAP^KO^, or TCRα^KO^ mice.(B and C) Quantification of GC frequency in popliteal LNs (B) and PPs (C), as in (A).(D) Representative flow cytometry plots and graph of dark zone (DZ) (CXCR4^hi^ CD86^lo^) and light zone (LZ) (CXCR4^lo^ CD86^hi^) GC B cell distribution in the PPs of WT and SAP^KO^ mice.(E) Bcl6 transcript in sorted GC B cells derived from PPs of WT and SAP^KO^ mice.(F) Representative histogram and quantification of Bcl6 expression in GC B cells of WT and SAP^KO^ mice; the naive B cell population is shown as a negative control.(G) Representative images of mediastinal LNs of influenza-infected mice. LNs were fixed, sectioned, and stained for GL-7 (fluorescein isothiocyanate \[FITC\], green) and IgD (AF-647, white) to mark the GC and the B cell follicle. Hoechst was used for nuclear staining. Scale bar, 50 μm.(H) Representative flow cytometry plots showing GC B cells (Ki67^+^ Bcl6^+^) in the mediastinal LNs of WT, SAP^KO^, and TCRα^KO^ mice, 14 days following influenza infection. GC frequencies are summarized in the graph.Data are pooled from two (B, D--F, and H) and four (C) independent experiments. Each dot represents a single mouse; line represents the mean. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.0001, one-way ANOVA with Bonferroni posttest in (B), (C), and (H) and two-tailed Student's t test in (D)--(F). ns, not significant.

Many chronic GCs are found within PPs, and therefore it is difficult to discern whether these GCs are driven by specific gut-derived antigens. To examine whether SAP is required for pathogen-induced GC formation within other mucosal tissues, we infected WT, SAP-, and TCRα-deficient mice intranasally with an influenza A virus (×31), and examined the draining mediastinal LNs of the lungs by flow cytometry and immunofluorescence staining after 14 days. In response to viral infection, GC B cells (e.g., Ki67^+^, Bcl6^+^) were detected in the mediastinal LNs of WT mice, but not in TCRα-deficient mice, demonstrating that T cells are essential for GC formation in this organ as well ([Figures 2](#fig2){ref-type="fig"}G and 2H). Conversely, a clear GC cell population was detected in the mediastinal LNs of infected SAP-deficient mice; however, this GC population was 2.4-fold smaller compared to that observed in WT mice ([Figures 2](#fig2){ref-type="fig"}G and 2H). Thus, we conclude that similar to chronic immune responses in gut lymphoid organs, SAP is not essential for GC formation in response to specific viral infection within the lung-draining LNs.

To gain additional insight into the role of SAP in viral infection, we examined whether chronic exposure to immune stimulation promotes GC formation in SAP-deficient mice. It was previously demonstrated that GC formation was severely defective in chronically infected SAP-deficient mice; however, a very small GC B cell population was observed ([@bib20]). To further investigate this result, we repeated this specific experiment and compared GC formation in SAP-deficient mice in response to either chronic lymphocytic choriomeningitis virus (LCMV~cl13~) or acute (LCMV~arm~) infection. We detected a small population of GC B cells (9.8-fold less than WT) in LCMV~cl13~-infected mice 30 days after infection, whereas GC B cells were not detected in response to administration of the acute virus ([Figure S1](#mmc1){ref-type="supplementary-material"}). We conclude that chronic exposure to antigen may promote the formation of GC B cells to some extent independently of SAP functions.

The Frequency of Tfh Cells in PPs Is Proportional to GC Size {#sec2.3}
------------------------------------------------------------

It was previously shown that in SAP-deficient mice, Tfh cell formation is severely impaired ([@bib59]). We examined using flow cytometry analysis whether sufficient Tfh cells are formed in the PPs of SAP-deficient mice. We found that the frequency of activated Th cells (CD44^hi^ CD62L^lo^) was similar between WT and SAP-deficient mice ([Figures 3](#fig3){ref-type="fig"}A and 3C); however, the frequency of Tfh cells, based on CXCR5 and PD-1 marker expression, was 4-fold lower compared to WT mice ([Figures 3](#fig3){ref-type="fig"}B and 3D). Nonetheless, a clear population of CD4^+^ cells that expressed high levels of CXCR5, PD-1, and the Tfh transcription factor Bcl6 was present in the PPs of SAP-deficient mice ([Figure 3](#fig3){ref-type="fig"}E). The GC B cell:Tfh ratio was similar between SAP-deficient and WT mice, suggesting that sufficient numbers of T cells were available for each GC B cell ([Figure 3](#fig3){ref-type="fig"}F). It was previously suggested that CXCR5^+^ CD8 T cells can provide T cell help to B cells ([@bib61]); however, the depletion of CD8 T cells in PPs had no measurable effect on the GC size, whereas depletion of CD4 or total T cells had a dramatic effect ([Figure S2](#mmc1){ref-type="supplementary-material"}). Thus, optimal generation of Tfh cells in PPs depends on the expression of SAP in CD4 T cells; nonetheless, their proportion relative to GC B cells is not perturbed in SAP^KO^ mice.Figure 3The Proportion of Tfh Cells in PP GCs Is Maintained in SAP-Deficient Mice(A) Representative flow cytometry plots showing activated Th cell (CD44^hi^ CD62L^lo^) frequencies in the PPs of WT and SAP^KO^ mice.(B) Representative flow cytometry plots showing Tfh cells (CXCR5^+^ PD-1^+^) gated from the activated T cell population in the PPs of WT and SAP^KO^ mice.(C and D) Graphs showing the frequencies of CD4^+^ activated (C) and Tfh cells (D), as in (A) and (B), respectively.(E) Representative histogram showing Bcl6 expression in WT and SAP^KO^ Tfh cells. Expression in naive T cells is shown as a negative control, and frequencies are summarized in the graph.(F) Graph showing the ratio between GC B cells and Tfh cells in WT and SAP^KO^ PPs.(G--I) Representative histogram and quantification of ICOSL (G), CD40 (H), and ICAM-1 (I) expression in PP GC B cells.(J) Representative flow cytometry plots showing EdU uptake by WT and SAP^KO^ GC B cells, 2.5 h following EdU administration. Frequencies of EdU^+^ cells are summarized in the graph.Data are pooled from two independent experiments, with three mice in each experiment. Each dot represents a single mouse; line represents the mean. ^∗^p \< 0.05, ^∗∗∗^p \< 0.0001, two-tailed Student's t test. ns, not significant.

Next, we examined whether B cells in the GCs of SAP-deficient mice express molecules that mediate the delivery of T cell help and proliferation-induced signals ([@bib11], [@bib45], [@bib72]). Although the expression levels of some adhesion molecules on GC T and B cells in lymph nodes were slightly different in the PPs ([Figure S3](#mmc1){ref-type="supplementary-material"}), we found that the receptors controlling T cell-B cell interactions and delivery of T cell help, including ICOSL, CD40, and ICAM-1 on B cells, were normally expressed in SAP-deficient mice ([Figures 3](#fig3){ref-type="fig"}G--3I). T cells select B cells by providing them with signals that enhance their proliferation in the DZ ([@bib29], [@bib30], [@bib65]). Analysis of proliferation by 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay revealed no defect in B cell division within the GCs of SAP-deficient mice ([Figure 3](#fig3){ref-type="fig"}J). These results show that GC B cells in PPs have the capacity to receive help signals and proliferate independently of SAP-mediated T cell help.

SAP-Mediated T Cell Help Is Not Required for CSR to IgA and IgG2a/b {#sec2.4}
-------------------------------------------------------------------

CSR to IgG1 isotype is highly dependent on the delivery of T cell help to B cells, whereas class switch to IgA can take place without T cells or CD40 signals ([@bib1], [@bib7], [@bib8], [@bib47]). However, since GCs do not form in CD40- or TCRα-deficient mice, it remained unclear whether the formation of IgA^+^ GC B cells depends on T cell functions. Our imaging experiments revealed that AID is expressed in the PPs of SAP-deficient mice, indicating that CSR can take place. To investigate the role of SAP in the formation of IgA^+^ GC B cells, we compared the expression of IgM, IgG1, and IgA in GC cells derived from either WT or SAP-deficient mice by flow cytometric analysis. We found that IgG1 class switched B cells were nearly absent from the GCs of PPs, while the frequency of IgA^+^ and IgM^+^ GC B cells was increased ([Figures 4](#fig4){ref-type="fig"}A and 4B). Furthermore, IgA antibodies were detected in the intestinal contents of SAP-deficient mice, whereas no IgG1 antibodies were detected in the serum of these mice ([Figures 4](#fig4){ref-type="fig"}C and 4D). GC B cells in the PPs of SAP-deficient mice expressed AID ([Figure 1](#fig1){ref-type="fig"}C) in addition to transcripts of genes that mediate CSR, including *IL4Ra*, *IL21R*, *Stat3*, and *Stat6* ([Figure 4](#fig4){ref-type="fig"}E), suggesting that they are able to receive T cell help that induces CSR to IgG1. These experiments demonstrate that although the generation of IgA^+^ GC B cells depends on T cell functions, it does not depend on SAP-mediated T cell help. Nonetheless, CSR to IgG1 is strictly SAP dependent, even when T cell-dependent GCs are generated. We conclude that T cell help to B cells, which promotes CSR to IgG1, is uncoupled from T cell functions that promote GC formation.Figure 4SAP-Mediated T Cell Help Is Not Required for Generation of IgA^+^ GC B Cells in PPs(A) Representative flow cytometry plots showing IgG1 and IgA isotype frequency gated from GC B cells derived from WT or SAP-deficient mice.(B) Quantification of GC isotype frequencies, as shown in (A). Data are pooled from four independent experiments; each dot represents a single mouse; line represents the mean.(C) Levels of IgG1 in the sera of WT and SAP^KO^ mice as estimated by standard ELISA.(D) Quantification of IgA antibodies in the intestinal contents of WT and SAP^KO^ mice as measured by ELISA.(E) qPCR for IL21R, IL4R, STAT3, and STAT6 transcripts in sorted GC B cells (GL7^+^ FAS^+^) derived from PPs of WT and SAP^KO^ mice.Data are pooled from two independent experiments with two mice in each experiment. Each dot represents a single mouse, line represents the mean. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.0001, two-tailed Student's t test. ns, not significant.

GCs were also detected in the GCs of SAP-deficient mice that were infected with influenza A virus ([Figures 2](#fig2){ref-type="fig"}G and 2H). These GCs contained primarily IgG2a/b^+^ B cells, with very few IgG1^+^ and IgA^+^ B cells ([Figure S4](#mmc1){ref-type="supplementary-material"}). As observed in the PPs of SAP-deficient mice, IgG1^+^ B cells were absent from these GCs; however, the frequency of IgG2a/b^+^ B cells was similar to those in WT mice ([Figure S4](#mmc1){ref-type="supplementary-material"}). We conclude that CSR to IgG1 is strictly SAP dependent, whereas the generation of other isotypes does not depend on this molecule.

Clonal Diversification Is Uncoupled from Affinity-Dependent Selection Forces in PP GCs {#sec2.5}
--------------------------------------------------------------------------------------

The formation of GCs in SAP-deficient mice raises the question of whether these structures can support GC functions, including clonal diversification and selection of the best B cell variants for clonal expansion. To address this question, we sorted individual IgA^+^ GL-7^+^ FAS^+^ B cells from single PPs of WT and SAP-deficient mice and sequenced their *Igh* mRNA, followed by CDR3-based clustering ([Figure S5](#mmc1){ref-type="supplementary-material"}A). In WT mice, V-segment usage was highly diverse (∼40/PP) and many clones bearing distinct CDR3s were detected within the GC compartment ([Figures 5](#fig5){ref-type="fig"}A and 5B). In contrast, in the PPs of SAP-deficient mice, we found limited V-segment usage (∼15/PP), and analysis of the unique CDR3 sequence frequency revealed 2.17-fold fewer distinct B cell clones in the GCs of SAP^KO^ mice ([Figures 5](#fig5){ref-type="fig"}A and 5B). Furthermore, the GCs of SAP-deficient mice were dominated by 2--3 highly expanded clones, which consisted of 89.85% of the total GC cells ([Figure 5](#fig5){ref-type="fig"}B). To examine whether the reduced number of clones in the GCs of SAP-deficient mice is indeed a result of defects in T cell function in GCs, we depleted CD4^+^ T cells by injecting anti-CD4 antibody into WT mice. After 2 weeks, although CD4 T cells were efficiently depleted within the PPs of WT mice, IgA^+^ GC B cells were still evident ([Figures S5](#mmc1){ref-type="supplementary-material"}B--S5D). Analysis of clonal diversity under these conditions revealed a 2-fold reduction in V-segment usage and a 2.2-fold decrease in the frequency of individual CDR3 sequences ([Figures 5](#fig5){ref-type="fig"}A and 5B). We conclude that SAP-mediated T cell functions promote clonal diversity in the GC reaction within PPs.Figure 5Clonal Diversification Is Uncoupled from Selection Forces in PP GCs(A) The number of V-regions detected in IgA sequences of GC-derived (GL7^+^ FAS^+^ IgA^+^) B cells recovered from a single PP derived from either WT, SAP^KO^, or WT mice treated with αCD4-depleting antibody for 14 days (WT + αCD4).(B) Clonal distribution based on CDR3 sequences, as in (A). Colored fractions represent expanded CDR3 sequences (\>2); white fraction represents single clones. Each pie chart represents one mouse (n = 2). The number of sequenced cells is indicated in the center circle.(C) Number of mutations per B cell of the cells described in (A). Data are pooled from two independent experiments with one mouse in each experiment. ^∗∗^p \< 0.01, one way ANOVA with Bonferroni posttest. ns, not significant.(D--F) Lineage-tree analysis of clonally related sequences in WT (D), SAP^KO^ (E), and WT + αCD4 (F) GC B cells. The number of mutations between neighboring nodes is indicated and includes synonymous, non-synonymous, and reverse mutations to the germline sequence. GL, germline; UCA, unique common ancestor, inferred from the sequence analysis.(G and H) Graphs showing the density of selection strength for all analyzed sequences within the framework (FWR) (G) or complementary determining region (CDR) (H) of WT, SAP^KO^, and αCD4 treated mice. Selection was estimated using BASELINe focused test with the RS5NF mutability model. ^∗^False discovery rate (FDR) \< 0.05.

GC B cells express AID, an enzyme that mediates random SHM and diversification of clones over time, followed by selection of the high-affinity variants. Since GC B cells in SAP-deficient mice express AID, we examined whether SAP is required for clonal diversification by SHM followed by a selection stage. Comparison of the mutation number per cell revealed that GC B cells in SAP-deficient mice accumulated a significant number of mutations in their immunoglobulins, although to a lesser extent than in WT mice ([Figure 5](#fig5){ref-type="fig"}C). Although clonal diversity was reduced in anti-CD4 treated mice ([Figures 5](#fig5){ref-type="fig"}A and 5B), reduction in the number of SHM per cell was not observed, suggesting that these highly mutated cells persisted after CD4 depletion within PP GCs in a T cell-independent manner ([Figure 5](#fig5){ref-type="fig"}C). These findings indicate that SHM and clonal diversification within the GC reaction can take place in the absence of SAP-mediated T cell help.

To examine whether positive selection takes place in the GCs of SAP-deficient mice, we reconstructed lineage trees of clones recovered from PPs. In WT mice, we found several families of clones that exhibited clonal diversification by progressive SHM accumulation and by clonal bursts ([Figure 5](#fig5){ref-type="fig"}D). Analysis of the dominant clones in SAP-deficient mice revealed extensive clonal diversification, including clonal burst events that gave rise to many diverse progeny B cells ([Figure 5](#fig5){ref-type="fig"}E). These clonal lineages contained more members compared to WT GC B cells, since more clonally related cells were recovered from SAP-deficient mice, as a result of lower clonal diversity in these GCs ([Figures 5](#fig5){ref-type="fig"}A and 5B). Similar results were observed in anti-CD4 treated mice ([Figure 5](#fig5){ref-type="fig"}F). Thus, progressive accumulation of SHM and clonal bursts can take place in GC B cells within PPs in a SAP-independent manner.

To investigate whether B cell selection forces play a role in the GCs of SAP-deficient mice, we applied BASELINe analysis to quantify the ratio of synonymous to non-synonymous nucleotide changes compared to null model expectations in the framework (FWR) and complementary determining regions (CDRs) of the *Igh* sequences ([@bib21], [@bib68]). Synonymous (silent) mutations do not change the encoded amino acid, and thus do not contribute to antibody affinity maturation, whereas non-synonymous mutations in the DNA, which result in changes in the nucleic acid code, may affect Ig affinity ([@bib68]). Hence, affinity-based clonal selection is characterized by an increase in the ratio of replacement versus silent mutations. We found that B cells in SAP-deficient mice showed a lower ratio of synonymous to non-synonymous mutations, both in the CDR and FWR sequences, compared to WT mice ([Figures 5](#fig5){ref-type="fig"}G and 5H). Furthermore, mice that were treated with anti-CD4 antibody for 2 weeks also showed a reduction in selection strength, but to a lesser extent than that observed in SAP-deficient mice ([Figures 5](#fig5){ref-type="fig"}G and 5H). Similar differences were observed when clones bearing the same V genes were compared between WT and SAP-deficient mice ([Figure S6](#mmc1){ref-type="supplementary-material"}). Since the BASELINe analysis compares each Ig sequence to its corresponding germline sequence, independent of clonal expansion, the difference in clonal divergence did not affect the results of this analysis. We conclude that selection forces within chronic GCs of the PP depend on SAP, whereas clonal diversification can take place in the absence of SAP-dependent T cell help.

Positive selection of B cells by T cells in GCs depends on the upregulation of Myc and its downstream genes ([@bib12], [@bib25]). To understand why positive selection is perturbed in the absence of SAP in PPs, we sorted GC B cells from WT and SAP-deficient mice and examined their transcriptome by bulk RNA sequencing analysis. We found that GC B cells derived from SAP-deficient mice show altered gene expression profiles ([Figure S5](#mmc1){ref-type="supplementary-material"}F). Gene set enrichment analysis (GSEA) revealed a reduction in Myc targets gene expression ([@bib51], [@bib63]). Thus, in the absence of SAP, GC B cells are unable to respond efficiently to T cell help and upregulate Myc-responsive genes that promote their selection and provide a differential advantage in clonal expansion ([Figure S5](#mmc1){ref-type="supplementary-material"}G).

Plasma Cell Generation in PPs Is Regulated by SAP in an Indirect Manner {#sec2.6}
-----------------------------------------------------------------------

T cell help to B cells is essential for the effective differentiation of GC B cells into PCs. In intestinal tissues, most of the IgA^+^ plasma cells are mutated in their *Igh* variable regions, indicating that they originate from PP GCs ([@bib43]). To examine whether SAP regulates the formation of PCs in PPs and the gut lamina propria, we generated SAP-deficient mice that express yellow fluorescent protein (YFP) under the promoter of the PC transcription factor Blimp-1 (Blimp-1-YFP). Flow cytometric analysis of cells derived from the PP and lamina propria of Blimp-1-YFP reporter mice revealed 2.39-fold and 2.86-fold, respectively, fewer Blimp-1^+^ cells in SAP-deficient mice compared to WT mice ([Figures 6](#fig6){ref-type="fig"}A and 6B). Furthermore, nearly all of the Blimp-1-YFP^+^ cells in the lamina propria of both WT and SAP^KO^ mice were IgA^+^ plasma cells ([Figure 6](#fig6){ref-type="fig"}C). These findings suggest that SAP is required for PC formation; however, the diminished number of Blimp-1^+^ cells may also be a result of the small size of GCs formed in SAP-deficient mice. To examine this possibility, we stained PP cells derived from SAP-deficient mice for the PC marker CD138 and normalized the cell frequency to the GC size. Flow cytometric analysis revealed that the PPs of SAP-deficient mice contain 5-fold fewer plasma cells compared to WT mice ([Figure 6](#fig6){ref-type="fig"}D). However, the PC:GC cell ratio was similar between WT and SAP-deficient mice ([Figure 6](#fig6){ref-type="fig"}E). Thus, we conclude that SAP controls PC formation in the gut at least partially through regulation of the GC size.Figure 6PC Generation in PPs Is Regulated by SAP in an Indirect Manner(A) Representative flow cytometry plots and quantification of Blimp-1^+^ CD138^+^ cell population in the PPs of WT and SAP^KO^ Blimp-1-YFP reporter mice.(B) Representative flow cytometry plots and quantification of the Blimp-1^+^ Dump^−^ (CD4^+^ CD8^+^ F4/80^+^ Gr-1^+^) cell population in the lamina propria of WT and SAP^KO^ Blimp-1-YFP reporter mice.(C) Surface IgA frequency gated from the lamina propria Blimp-1^+^ cells shown in (B).(D) Representative flow cytometry plots and quantification of CD138^+^ cell population in PPs of WT and SAP^KO^ mice.(E) Graph showing the ratio between the frequency of CD138^+^ cells to GC size in PPs of WT and SAP-deficient mice.In (A)--(C), data are pooled from two independent experiments with three mice in each experiment; line represents the mean. In (D) and (E), data are pooled from five independent experiments, with coupled CD138 and GC staining; line represents the mean. ^∗^p \< 0.05, ^∗∗∗^p \< 0.0001, two-tailed Student's t test. ns, not significant.

Discussion {#sec3}
==========

Tfh cells are essential for GC formation and function in inducible GCs in response to immunization and pathogen invasion ([@bib67]). Here, we defined the role of SAP-mediated T cell functions in chronic GCs within PPs. We demonstrate the following: (1) in PPs, small bona fide chronic GCs are formed in the absence of SAP-dependent T cell help that host IgA^+^ B cells and generate PCs; (2) B cell diversification in these GCs through progressive SHM and clonal bursts is SAP independent; and (3) T cell-imposed selection forces in PP GCs require SAP. Thus, as opposed to B cell responses to model antigens and some viral infections in peripheral LNs, we find that in chronic GCs within PPs, SAP is not essential for most T cell-dependent B cell functions.

SAP is essential for GC formation in response to immunization ([@bib59]), and it is most likely that its functional dichotomy between the LNs and PPs can be attributed to the chronic nature of the PP GC reaction and the harsh environment of the gut. Constant exposure to antigens may provide sufficient stimulation over time to support the formation of Tfh cells and GC seeding in the PPs, even when T cell functions are defective. It was previously demonstrated that Tfh cell development and functions in the LNs of SAP-deficient mice can be recovered upon injection of a large amount of cognate peptide to mice ([@bib22]). This model may represent a chronic antigen exposure scenario or a response to a large number of T cell antigens. It was shown that SAP-independent GC seeding does not take place in the spleen, even during chronic viral infection; however, close examination of the data suggests that a very small GC population does form in the infected mice ([@bib20]). We repeated these experiments and identified a small but significant GC cell population in mice that were infected with chronic LCMV~cl13~, which persists for a long time in the mouse. Furthermore, it was found that in chronic *Plasmodium* infection of SAP-deficient mice, small GCs were detected several weeks after exposure to the parasite, although GC functions such as SHM and affinity maturation were not examined ([@bib52]). In addition, it was demonstrated that GCs are not formed in SAP-deficient mice that were infected with influenza virus ([@bib38]); however, we found here that B cells in SAP-deficient mice that received a different dose of a different strain of influenza virus were able to form GCs. This observation is consistent with previous findings that show the generation of virus-specific class-switched antibodies in the lungs, independent of MHC class II expression on B cells ([@bib58]). These findings suggest that antigen-specific responses in GCs within the lungs can occur to some extent without cognate T cell help ([@bib23], [@bib42], [@bib58]). Thus, it seems that long-lasting chronic exposure to antigens can drive GC formation, even in the absence of SAP-dependent T cell help.

An additional mechanism that may bypass the need for SAP could be danger signals derived from gut-resident bacteria, independent of specific antigen recognition ([@bib62]). Although we did not exclude this possibility, this scenario is unlikely since non-specific B cell activation would lead to the expansion of polyclonal B cells, independent of antigen recognition, whereas GCs in SAP-deficient mice host few clones; nonetheless, the combination of microbial-derived signals with BCR ligation may trigger the GC response in SAP-deficient mice.

Since SAP-dependent T cell signals are not essential for GC formation in PPs, this type of T cell help may support a response against non-protein antigens. In adult mice and humans, nearly all of the IgA sequences recovered from lamina propria resident B cells were found to be highly mutated, suggesting that B cells that carry a BCR that is specific to a non-protein antigen can acquire SHM ([@bib44]). Highly mutated and expanded LPS-specific B cells were detected in the guts of both humans and mice ([@bib39], [@bib44]). Thus, it is possible that upon antigen encounter, naive or memory B cells can invade pre-existing GCs, wherein cognate T cell help is not a prerequisite for participating in the GC reaction. The mechanism of clonal diversification without cognate Tfh cells in GCs may efficiently expand the circulating memory B cell pool, and thereby continually fuel the clonally stable PC population in the lamina propria and support a progressive increase or a burst in SHM ([@bib5], [@bib9], [@bib44]). In addition, this pathway can contribute to the generation of low-affinity B cell clones within the chronic GCs of the PP and therefore support the mutualism between the host and microbiota ([@bib32], [@bib62]). In addition, we found that the ratio of Tfh cells:GC B cells was intact in PPs, indicating that sufficient numbers of Tfh cells were formed in SAP-deficient mice. However, we could not determine whether these cells are specific to the same antigen presented by GC B cells in the PPs. Regardless of antigen specificity in the chronic GCs that are formed in SAP-deficient mice, our findings demonstrate that clonal diversification can take place without the involvement of SAP-dependent T cell help. Nonetheless, competition for T cell help and clonal selection depend on SAP expression and antigen presentation ([@bib10]). These findings are reminiscent of the events that occur in the SED, wherein clonal expansion and PC formation take place in a T cell-dependent manner; however, selection of the high-affinity clones by T cells does not take place at this site ([@bib10]).

Collectively, our findings suggest that Tfh cells in the gut function differently than in other organs following an immunization or viral infection, indicating that SAP-dependent and SAP-independent GC reactions co-exist in PPs. These observations suggest that the traditional classification of the B cell immune responses as T cell-dependent or T cell-independent responses does not describe the full complexity of the GC reaction and, in particular, chronic GCs, as in PPs. Understanding immune-cell interactions in chronic GCs under homeostatic conditions may open new avenues in the development of oral vaccination strategies.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**CD45R Monoclonal Antibody (RA3-6B2), APC-Alexa Fluor 750Thermo Fisher ScientificCat\# RM2627, RRID:[AB_10371897](nif-antibody:AB_10371897){#intref0010}V500 Rat anti-Mouse CD45R/B220 (Clone RA3-6B2)BD biosciencesCat.\#561226CD45R (B220) Monoclonal Antibody (RA3-6B2), eFluor 450Thermo Fisher ScientificCat\# 48-0452-82, RRID:[AB_1548761](nif-antibody:AB_1548761){#intref0015}Brilliant Violet 605 anti-mouse CD138 (Syndecan-1) antibodyBioLegendCat\# 142531, RRID:[AB_2715767](nif-antibody:AB_2715767){#intref0020}Anti-Mouse CD38 Alexa Fluor 700Thermo Fisher ScientificCat\# 56-0381-82, RRID:[AB_657740](nif-antibody:AB_657740){#intref0025}F4/80 Monoclonal Antibody (BM8), APC-eFluor 780, eBioscienceThermo Fisher ScientificCat\# 47-4801-80, RRID:[AB_2637188](nif-antibody:AB_2637188){#intref0030}PE-Cy7 Hamster Anti-Mouse CD95 (Clone Jo2)BD biosciencesCat\# 557653, RRID:[AB_396768](nif-antibody:AB_396768){#interref260}Alexa Fluor® 647 anti-mouse/human GL7 AntigenBioLegendCat\# 144605, RRID:[AB_2562184](nif-antibody:AB_2562184){#intref0035}FITC anti-mouse/human GL7 AntigenBioLegendCat\# 144604, RRID:[AB_2561697](nif-antibody:AB_2561697){#intref0040}PerCP/Cy5.5 anti-mouse/human GL7 AntigenBioLegendCat\# 144609, RRID:[AB_2562978](nif-antibody:AB_2562978){#interref265}Biotin anti-mouse IgABioLegendCat\# 407003, RRID:[AB_315078](nif-antibody:AB_315078){#intref0045}Mouse IgA Monoclonal Antibody (mA-6E1), PEThermo Fisher ScientificCat\# 12-4204-81, RRID:[AB_465916](nif-antibody:AB_465916){#intref0050}Brilliant Violet 421 anti-mouse IgG1BioLegendCat\# 406615, RRID:[AB_2562233](nif-antibody:AB_2562233){#intref0055}Mouse IgM Monoclonal Antibody (II/41), PerCP-eFluor 710Thermo Fisher ScientificCat\# 46-5790-82, RRID:[AB_1834435](nif-antibody:AB_1834435){#intref0060}Streptavidin APC-eFluor 780 100 ugThermo Fisher ScientificCat\# 47-4317-82, RRID:[AB_10366688](nif-antibody:AB_10366688){#intref0065}Alexa Fluor® 488 anti-mouse CD4BioLegendCat\# 100423, RRID:[AB_389302](nif-antibody:AB_389302){#intref0070}CD4 Monoclonal Antibody (RM4-5), APC-eFluor 780Thermo Fisher ScientificCat\# 47-0042-80, RRID:[AB_1272219](nif-antibody:AB_1272219){#intref0075}CD44 Monoclonal Antibody (IM7), PEThermo Fisher ScientificCat\# A25999, RRID:[AB_2536059](nif-antibody:AB_2536059){#intref0080}CD62L (L-Selectin) Monoclonal Antibody (MEL-14), Alexa Fluor 700Thermo Fisher ScientificCat\# 56-0621-82, RRID:[AB_494003](nif-antibody:AB_494003){#intref0085}CD8a Monoclonal Antibody (53-6.7), APC-eFluor 780Thermo Fisher ScientificCat\# 47-0081-82, RRID:[AB_1272185](nif-antibody:AB_1272185){#intref0090}Ly-6G/Ly-6C Monoclonal Antibody (RB6-8C5), Super Bright 780Thermo Fisher ScientificCat\# 78-5931-82, RRID:[AB_2744921](nif-antibody:AB_2744921){#intref0095}F4/80 Monoclonal Antibody (BM8), APC-eFluor 780Thermo Fisher ScientificCat\# 47-4801-80, RRID:[AB_2637188](nif-antibody:AB_2637188){#intref0100}Pacific Blue anti-mouse CD62LBioLegendCat\# 104424, RRID:[AB_493380](nif-antibody:AB_493380){#intref0105}PE/Cy7 anti-mouse CD279 (PD-1)BioLegendCat\# 109110, RRID:[AB_572017](nif-antibody:AB_572017){#intref0110}Biotin anti-mouse CD185 (CXCR5)BioLegendCat\# 145509, RRID:[AB_2562125](nif-antibody:AB_2562125){#intref0115}BCL6 Monoclonal Antibody (BCL-UP), PerCP-eFluor 710Thermo Fisher ScientificCat\# 46-9880-42, RRID:[AB_11063697](nif-antibody:AB_11063697){#intref0120}Biotin anti-mouse CD275 (B7-RP1, ICOSL, B7H2)BioLegendCat\# 107403, RRID:[AB_345259](nif-antibody:AB_345259){#intref0125}BV421 Rat Anti-Mouse CD40BD BiosciencesCat\# 562846, RRID:[AB_2734767](nif-antibody:AB_2734767){#intref0130}Alexa Fluor® 488 anti-mouse CD54BioLegendCat\# 116111, RRID:[AB_493494](nif-antibody:AB_493494){#intref0135}Alexa Fluor(R) 647 anti-mouse CD102BioLegendCat\# 105612, RRID:[AB_2122182](nif-antibody:AB_2122182){#intref0140}PE anti-mouse CD11a/CD18 (LFA-1)BioLegendCat\# 141006, RRID:[AB_10694371](nif-antibody:AB_10694371){#intref0145}APC anti-mouse CD86BioLegendCat\# 105114, RRID:[AB_313167](nif-antibody:AB_313167){#intref0150}Brilliant Violet 421 anti-mouse CD184 (CXCR4)BioLegendCat\# 146511, RRID:[AB_2562788](nif-antibody:AB_2562788){#intref0155}PE anti-mouse CD3BioLegendCat\# 100205, RRID:[AB_312662](nif-antibody:AB_312662){#intref0160}Anti-IgG2ab-VioBright FITCMiltenyi BiotecCat\# 130-104-579, RRID:[AB_2661523](nif-antibody:AB_2661523){#intref0165}Goat polyclonal Secondary Antibody to Mouse IgG1 - heavy chain (HRP)AbcamCat\# ab97240, RRID:[AB_10695944](nif-antibody:AB_10695944){#intref0170}Alexa Fluor® 647 anti-mouse IgDBioLegendCat\# 405707, RRID:[AB_893529](nif-antibody:AB_893529){#intref0175}InVivoMab anti-mouse CD4 (GK1.5)Bio X CellCat\# BE0003-1, RRID:[AB_1107636](nif-antibody:AB_1107636){#intref0180}Ultra-LEAF Purified anti-mouse CD8a (53-6.7)BioLegendCat\# 100746, RRID:[AB_11147171](nif-antibody:AB_11147171){#intref0185}**Bacterial and Virus Strains**Recombinant influenza X31-GP33 virusLintermann laboratoryNALCMV-clone 13Iannacone laboratoryNALCMV-ArmstrongIannacone laboratoryNA**Chemicals, Peptides, and Recombinant Proteins**Alexa Fluor® 647 StreptavidinBioLegendCat\# 405237NP-OVAL (Ovalbumin)Biosearch TechnologiesCat\# 10643Imject Alum AdjuvantThermo Fisher ScientificCat\# 77161Mouse IgA ELISA Quantitation SetBethyl LaboratoriesCat\# E90-103Hoechst 33342Thermo Fisher ScientificCat\# H3570TRI ReagentSigma-AldrichCat\# T9424Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay KitThermo Fisher ScientificCat\# C10425qScript cDNA Synthesis KitQuanta BioCat\# 95047Qubit dsDNA HS Assay KitThermo Fisher ScientificCat\# Q32854LightCycler® 480 SYBR Green I MasterRocheCat\# 04707516001Tissue-Tek® O.C.T. CompoundSakuraCat\# 4583Mounting mediumSigma-AldrichCat\# M1289**Deposited Data**BCR-seq of IgA^+^ GC B cellsThis paperENA: PRJEB36003RNA-seq of GC B cellsThis paperGEO: [GSE142640](ncbi-geo:GSE142640){#intref0190}**Experimental Models: Organisms/Strains**WT: C57BL/6EnvigoNAAID^Cre^: B6.129P2-*Aicda*^*tm1(cre)Mnz*^/JJackson LaboratoriesCat\# 007770 RRID:IMSR_JAX:007770Rosa26^flox-stop-flox-tdTomato^:B6.Cg-Gt(ROSA)26Sor^tm9(CAG-tdTomato)Hze^/JJackson LaboratoriesCat\# 007909 RRID:IMSR_JAX:007909Blimp-1-YFP: B6.Cg-Tg(Prdm1-EYFP)1Mnz/JJackson LaboratoriesCat\# 008828 RRID:IMSR_JAX:008828TCRα^KO^: B6.129S2-Tcra^tm1Mom^/JJackson LaboratoriesCat\# 002116 RRID:IMSR_JAX:002116AID-GFP: C57BL/6-Tg(Aicda/EGFP)1Rcas/JNussenzweig laboratoryCat\# 018421 RRID:IMSR_JAX:018421SAP^KO^: B6.129S6-Sh2d1a^tm1Pls^/JJackson LaboratoriesCat\# 025754 RRID:IMSR_JAX:025754**Oligonucleotides**See [Table S1](#mmc1){ref-type="supplementary-material"} for qPCR primer sequencesThis paperNA**Software and Algorithms**Flowjo 10Tree Star<https://www.flowjo.com/>Prism 5Graphpad Software<https://www.graphpad.com/>Prism 7Graphpad Software<https://www.graphpad.com/>BASELINe[@bib68]<http://selection.med.yale.edu/baseline>MARS-seq Pipeline[@bib40]NAPartek Genomics Suite Analysis softwarePartek<https://www.partek.com/partek-genomics-suite/>GSEA[@bib63]; [@bib51]<http://software.broadinstitute.org/gsea/index.jsp>Imaris 9.1.2Bitplane<https://imaris.oxinst.com/>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ziv Shulman (<ziv.shulman@weizmann.ac.il>). This study did not generate new unique reagents.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

Aicda^Cre^, Rosa26^Stop-tdTomato^, Sh2d1a^−/−^ (SAP^KO^), Blimp-1-YFP and TCRα^−/−^ (TCRα^KO^) mice were purchased from the Jackson Laboratories. AID-GFP mice were provided by Prof. Michel Nussenzweig. SAP knockout mice (Sh2d1a^−/−^) were previously described ([@bib19]). Sh2d1a^−/−^ mice were bred with Aicda^Cre/+^ Rosa26^Stop-tdTomato^ and AID-GFP mice. Wild-type mice (C57BL/6) were purchased from Envigo. All mice were between the age of 8-12 weeks at the start of the experiment and no differences were observed between males and females. Mice were bred and housed in specific pathogen free conditions and all experiments were conducted under protocols approved by the Weizmann Institute Animal Care and Use Committee (IACUC).

### Immunizations, treatments and viral infections {#sec4.3.2}

For NP-OVA immunizations, mice were injected with 25 μl PBS containing 10 μg NP16- OVA precipitated in alum (2:1) into the hind footpads. For influenza A virus infection experiments, mice were administered 10^4^ plaque-forming units (PFU) of influenza A/Hong Kong/1/1968/x31 (x31) virus, 4 × 10^5^ IU intranasally under inhalation anesthesia as previously described ([@bib23]). For LCMV infection, mice were infected intravenously with 2x10^6^ or 2x10^5^ PFU of LCMV~cl13~ or LCMV~arm~, respectively ([@bib57]). For CD4^+^ T cell depletion experiments, 200 μg of rat anti-mouse CD4 mAb (clone GK1.5, rIgG2b, BioXcell) or/and rat anti-mouse CD8 mAb (clone 53-6.7, rIgG2a, Biolegend) were injected intravenously 4 days prior to analysis. For Igh sequencing experiment, mice were injected with the depleting antibody every 4 days until analysis.

Method Details {#sec4.4}
--------------

### ELISA {#sec4.4.1}

Serum was collected from unimmunized mice, and IgG1 antibodies were detected by ELISA using anti-mouse IgG1-horseradish peroxidase. For IgA detection in the intestinal content, the small intestines were flushed with 2 mL PBS and collected into a tube. Samples were span down to remove feces and the supernatant was used for IgA detection by mouse IgA ELISA quantification set (Bethyl Laboratories).

### *In vivo* EdU proliferation assay {#sec4.4.2}

For proliferation measurements, mice were injected intravenously with 2 mg of the nucleoside analog 5-ethynyl-2′-deoxyuridine (EdU) (Molecular Probes) in PBS. After 2.5 hours, the PPs were dissected and cells were then stained for surface antigens as described, followed by EdU detection using Click-iT EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Molecular Probes) according to manufacturer's protocol.

### Flow cytometry {#sec4.4.3}

Small intestines were excised and washed with ice cold PBS to remove fecal content. Peyer's patches were harvested and forced through a mesh into PBS containing 2% fetal calf serum and 1 mM EDTA. For blockade of Fc receptors, single cell suspensions were incubated with 2 μg/ml anti-16/32 (clone 93) for 5 min. Cells were washed and incubated with fluorescently labeled antibodies for 30 min. GC cells were gated as live/single, B220^+^ CD38^-^ FAS^+^ or B220^+^ GL-7^+^ FAS^+^. Tfh cells were gated as CD4^+^ CD44^+^ CD62L^-^ PD-1^+^ CXCR5^+^. Intracellular staining for Bcl6 was performed using Foxp3 / Transcription Factor Staining Buffer Set (eBioscience) according to the manufacturer's instructions. Stained cell suspensions were analyzed using a CytoFlex flow cytometer (Beckman Coulter).

### Quantitative PCR analysis {#sec4.4.4}

Total RNA was isolated using Trizol Reagent (Sigma-Aldrich) according to the manufacturer's instructions. Total RNA was subjected to cDNA synthesis using qScript synthesis kit (Quanta bio). cDNA concentration was assessed with Qbit, using the dsDNA high-sensitivity assay kit (Thermo Fisher Scientific). qPCR mix was prepared using SYBR green (Roche) with primers described in [Table S1](#mmc1){ref-type="supplementary-material"}. Relative transcript expression was calculated using the ddCt method and all transcripts were normalized to HPRT.

### Immunohistochemistry {#sec4.4.5}

Mediastinal lymph nodes were fixed with 4% paraformaldehyde fixative for 16 hours and then dehydrated in 30% sucrose overnight before being embedded in OCT (Tissue-Tek). OCT-embedded 10-mm cryostat sections were dehydrated in acetone prior to freezing. Sections were rehydrated in PBS and incubated with 1% SDS in PBS for 5 min. Sections were then blocked in PBS with 0.05% Tween-20 and 3% BSA for 1 hour prior to staining. Slides were stained with FITC conjugated anti-mouse GL-7 (diluted 1:100) and Alexa Fluor 647 conjugated anti-mouse IgD (1:200) (BioLegend) in 1%BSA in PBS/T overnight. Slides were washed and stained shortly with Hoechst (1:20,000) (Thermo Fisher Scientific). Sections were mounted with mounting medium (Sigma-Aldrich) and examined with a Zeiss LSM 880 confocal microscope. Imaging data were analyzed with Imaris 9.2 (Bitplane).

### Image acquisition by TPLSM {#sec4.4.6}

Zeiss LSM 880 upright microscope fitted with Coherent Chameleon Vision laser was used for whole lymph node scan imaging experiments. Images were acquired with a femtosecond-pulsed two-photon laser tuned to 940 nm. The microscope was fitted with a filter cube containing 565 LPXR to split the emission to a PMT detector (with a 579-631 nm filter for tdTomato fluorescence) and to an additional 505 LPXR mirror to further split the emission to 2 GaAsp detectors (with a 500-550nm filter for GFP fluorescence). Tile images were acquired as a 120-180 μm Z stacks with 10 μm steps between each Z-plane. The zoom was set to 1.5, and pictures were acquired at 512 × 512 x-y resolution.

### Image analysis {#sec4.4.7}

In the whole lymph node scan images, quantification of GC size was performed using Imaris software (Bitplane). Each GC structure was segmented separately using the Imaris 3D surface object and area measurements were used.

### Single cell Igh sequencing {#sec4.4.8}

Single PP was harvested from WT and SAP- deficient mice and processed for flow cytometry analysis. Cell suspensions were gated as B220^+^ GL-7^+^ FAS^+^ IgA^+^ representing GC cells ([Figure S5](#mmc1){ref-type="supplementary-material"}). Cell sorting was performed using a FACS Aria II cell sorter (BD Bioscience). For total VDJ sequencing of Igα heavy chains, cells were sorted into 96 well plates containing lysis buffer (PBS containing 3 U/μl RNAsin, 10 mM dithiothreitol --DTT). cDNA was purified using random primers (NEB) as previously described ([@bib74]). Igα heavy chain sequence was amplified twice using primers for the Igα constant region (5′-ATCAGGCAGCCGATTATCAC-3′ for the first reaction and 5′-GAGGTGCAGCTGCAGGAGTCTGG-3′ for the second reaction) ([@bib44]) together with a mix of primers for the variable region ([@bib34]). The PCR products were sequenced and analyzed for CDR3 using web-based IgBlast and IMGT tools. Sequence alignment was performed using SnapGene software (GSL Biotech). For schematic representation of the results, sequences derived from single cells were clustered according to their CDR3 region and presented as percent of the total sequenced cells. Primer-derived mutations were excluded from the analysis.

### Igh sequence analysis {#sec4.4.9}

Ig Fasta sequences were aligned against the IMGT mouse heavy chain gene database (Sep. 2017) using NCBI IgBlast (version 1.7.0) ([@bib69]). Post processing of IgBlast output, and clonal clustering were performed using Change-O v0.3.7 (<https://changeo.readthedocs.io/>) ([@bib31]), Alakazam v0.2.8 (<https://alakazam.readthedocs.io>), SHazaM v0.1.8 (<https://shazam.readthedocs.io>), and custom scripts within the R statistical computing environment, as follows. V(D)J sequences were assigned to clonal groups by partitioning sequences based on identity of IGHV gene annotations, IGHJ gene annotations, and junction region lengths. Within these groups, sequences differing from one another by a hamming distance of 0.2 within the junction region were defined as clones by single-linkage clustering. Distances were measured and normalized by the length of the junction region. The clonal distance threshold was determined by manual inspection to identify the local minima between the two modes of the within-sample bimodal distance-to nearest histogram. Full-length germline sequences were reconstructed for each clonal cluster with D segment and N/P regions masked (replaced with Ns), with any ambiguous gene assignments within clonal groups resolved by the majority rule. Lineage trees were constructed for each clone having at least two unique sequences using PHYLIP (v3.695) ([@bib27]) and Alakazam. Selection quantification was calculated using BASELINe's local test ([@bib68]).

### RNA sequencing and gene set enrichment analysis {#sec4.4.10}

PPs were harvested from WT and SAP^KO^ mice and processed for flow cytometry analysis. Cell suspensions were stained for Dump- (CD4, CD8, Gr-1, F4/80) and B220^+^ CD138^-^ GL-7^+^ FAS^+^, representing GC B cells. Cell sorting was performed using a FACS Aria cell sorter (BD Bioscience). 5-10x10^3^ cells were sorted into 60μl of lysis/binding buffer (Life Technologies). mRNA was captured with 12 mL of oligo(dT) Dynabeads (Life Technologies), washed, and eluted at 85°C with 10 μl of 10 mM Tris-Cl (pH 7.5). MARS-seq was used as described ([@bib35]) to produce expression libraries with six replicates per strain. MARS-seq analysis was done using the UTAP transcriptome analysis pipeline ([@bib40]) of the Weizmann Institute Bioinformatics Unit. Reads were trimmed using Cutadapt ([@bib48]) and mapped to the Mus_musculus genome (UCSC mm10) using STAR ([@bib24]) v2.4.2a with default parameters. The pipeline quantifies the genes annotated in RefSeq (extended by 1000 bases toward the 5′ edge and 100 bases in the 3′ direction). Counting of sequenced reads was done using htseq-count ([@bib2]) (union mode). Genes having minimum of 5 UMI-corrected reads in at least one sample, were considered. Normalization of the counts and differential expression analysis was performed using DESeq2 ([@bib46]) with the parameters: betaPrior = True, cooksCutoff = FALSE, independentFiltering = FALSE. Raw P values were adjusted for multiple testing using the procedure of Benjamini and Hochberg. The threshold for significant differential expression was: padj ≤ 0.05, \|log2FoldChange\| \> = 1 and BaseMean \> = 5. Gene Set Enrichment Analysis (GSEA) was performed using GSEA 3.0 with the GSEAPreranked tool ([@bib51], [@bib63]). Gene names were converted to human gene symbols, and ran with default parameters for genes with BaseMean \> = 5. The Molecular Signature Database (MSigDB) hallmark gene sets was used to perform pathway enrichment analysis using a hypergeometric distribution and limiting the output to the top 1000 gene sets.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Students' t tests or one-way ANOVA with bonferroni posttest were used for statistical analysis and indicated in figure legends. Unless otherwise indicated, the data in figures were displayed as the mean ± SEM and n represents number of mice analyzed. p values are denoted in figures by: ns, not significant; ^∗^, p \< 0.05; ^∗∗^, p \< 0.01; ^∗∗∗^, p \< 0.0001. Statistical measurement was determined using Graphpad Prism Version 5.0.

Data and Code Availability {#sec4.6}
--------------------------

The accession number for all BCR sequencing data reported in this paper isENA: PRJEB36003. The accession number for all RNA-seq data reported in this paper is GEO: [GSE142640](ncbi-geo:GSE142640){#intref0250}. Custom scripts used for data analysis are available upon request. All other data are available in the main text or the supplementary materials.
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